Keyword: Nimbus Therapeutics
News
16.12.2022
-
Japanese pharma Takeda is acquiring Nimbus Lakshmi, a wholly-owned subsidiary of US clinical-stage drug discovery company Nimbus Therapeutics, and its tyrosine kinase 2...
News
07.04.2016
- US drug maker Gilead Sciences is to pay $400 million to Nimbus Therapeutics for its subsidiary Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program. The ACC program...